Bottom line
Is DOXBX a good fund? The bottom line
DOXBX is the Class X share class of Dodge & Cox Balanced Fund, an actively managed allocation / balanced mutual fund from Dodge & Cox.
It charges 0.42% — about $42 a year on every $10,000 invested, cheaper than 92% of allocation / balanced funds we track.
It returned +14.5% over one year, +9.5% a year over five years, +9.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $14.7 billion in net assets and 534 holdings, its largest position is CVS Health Corp. (2.3%) and the top 10 make up 16.9% of the portfolio.
What stands out
- Low cost: cheaper than 92% of allocation / balanced peers
- 5-year return beat 94% of category peers
- Broadly diversified (534 holdings)
- No front-end sales load
- Large and established ($14.7 billion)
Updated Nov 19, 2026
What DOXBX invests in
The Fund seeks income and long-term capital appreciation.
The Fund invests in a diversified portfolio of equity securities and debt securities. Under normal circumstances no less than 25% and no more than 75% of the Funds total assets will be invested in equity securities and no less than 25% of the Funds total assets will be invested in fixed income investments. The Fund may invest up to 30% of its total assets in equity or debt securities of non-U.S. issuers that are not in the S&P 500 Index, including emerging market issuers; provided that no more than 10% of the Funds total assets may be invested in non-U.S. dollar-denominated securities. Investments in non-U.S. issuers may be made indirectly by investing in another Fund managed by Dodge & Cox. Asset allocation between equity and debt securities is based on Dodge & Coxs assessment of the potential risks and returns for each asset class over a three- to five-year horizon. Factors used to…
From the fund's prospectus (filed Apr 22, 2026).
DOXBX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DOXBX | +14.5% | +9.5% | +9.8% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What DOXBX costs
On a $10,000 investment, DOXBX's 0.42% expense ratio costs about $42 a year. The prospectus estimates $587 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
DOXBX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | CVS Health Corp. CVS | 2.27% |
| 2 | Taiwan Semiconductor Manufacturing Co., Ltd. | 2.18% |
| 3 | Dodge & Cox Emerging Markets Stock Fund DODEX | 2.17% |
| 4 | The Charles Schwab Corp. SCHW | 2.09% |
| 5 | Humana, Inc. HUM | 1.56% |
| 6 | Alphabet, Inc. GOOG | 1.53% |
| 7 | RTX Corp. RTX | 1.38% |
| 8 | Gsk Plc GSK | 1.28% |
| 9 | Microsoft Corp. MSFT | 1.20% |
| 10 | U.S. Treasury Inflation Indexed | 1.19% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 16.9% of the fund. See all top 25 holdings and asset mix →